Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New Text-Based tool aims to help rural kids with ADHD

NCT ID NCT06743425

Disease control Sponsor: IDeA States Pediatric Clinical Trials Network Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests a remote monitoring program (RAMP) for children with ADHD living in rural areas. 36 children aged 5-11 who are starting or restarting stimulant medication will be randomly assigned to receive either text-based symptom questionnaires or digital education handouts. The goal is to see if the remote system is feasible and acceptable for families and doctors, not to measure clinical improvement.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Remote ADHD Monitoring Program (RAMP) - text-based questionnaires
What this could lead to
If successful, this could provide a practical way for rural families to track ADHD symptoms and share them with doctors, potentially improving treatment management.
What could go wrong
This is a very small pilot study (36 participants) focused on feasibility, not clinical outcomes. It may not show clear benefits or be scalable to larger populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 36 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

5 to 11 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: The child must * be under the care of a participating provider * be aged 5-11 at enrollment * have a diagnosis of ADHD * be initiating stimulant medication for treatment for the first time or have not received stimulant medication for the last 6 months * be attending in-person elementary school The Primary caregiver must * be willing and legally able to give consent * have access to a smartphone * be English-speaking * reside with the child at least 3 days per week * complete an initial symptom assessment prior to starting stimulant treatment and be willing to provide a copy to the study team The provider must * manage ADHD care in patients age 5-11 years * provide informed consent * agree to use the RAMP platform if they care for patients randomized to use it * agree to provide information to potential participants about the study and contact the research coordinator if interested Exclusion Criteria: Child: * has serious mental health comorbidities (Children with depression, anxiety, oppositional defiant disorder will be permitted to participate. Children with schizophrenia, bipolar disorder, conduct disorder and those who have been hospitalized for any mental health condition will be excluded from the study.) * has severe neurodevelopment disorders (Children with well-controlled seizure disorders will be permitted to participate.) * is currently receiving, or previously received, atypical antipsychotic medication treatment * is or becomes pregnant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADHD are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADHD Attention deficit hyperactivity disorder

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Medical University of South Carolina

    RECRUITING

    Charleston, South Carolina, 29425, United States

  • University of Mississippi Medical Center

    RECRUITING

    Jackson, Mississippi, 39216, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.